0001652917-15-000007.txt : 20151110
0001652917-15-000007.hdr.sgml : 20151110
20151109171054
ACCESSION NUMBER: 0001652917-15-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151105
FILED AS OF DATE: 20151109
DATE AS OF CHANGE: 20151109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9143477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 151216621
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-11-05
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research and Development
Common Stock
2015-05-28
5
G
0
1000.0
0.0
D
16405
D
Common Stock
2015-11-05
4
M
0
75000.0
30.63
A
97029
D
Common Stock
2015-11-05
4
F
0
4047.0
567.63
D
92982
D
Common Stock
2015-11-05
4
F
0
39605.0
567.63
D
53377
D
Common Stock
2015-11-05
4
M
0
25000.0
21.25
A
78377
D
Common Stock
2015-11-05
4
F
0
935.0
567.63
D
77442
D
Common Stock
2015-11-05
4
F
0
13312.0
567.63
D
64130
D
Common Stock
2015-11-06
4
S
0
9555.0
562.37
D
54575
D
Common Stock
2015-11-06
4
S
0
8345.0
563.43
D
46230
D
Common Stock
2015-11-06
4
S
0
2100.0
564.19
D
44130
D
Common Stock
2015-11-09
4
S
0
9694.0
558.37
D
34436
D
Common Stock
2015-11-09
4
S
0
1500.0
559.26
D
32936
D
Common Stock
2015-11-09
4
S
0
3900.0
560.31
D
29036
D
Common Stock
2015-11-09
4
S
0
500.0
561.36
D
28536
D
Common Stock
2015-11-09
4
S
0
5607.0
562.31
D
22929
D
Common Stock
2015-11-09
4
S
0
900.0
563.41
D
22029
D
Common Stock
14376
I
by GRAT
Common Stock
5599
I
By 401(k) Plan
Common Stock
10000
I
by GRAT
Non-Qualified Stock Option (right to buy)
21.25
2015-11-05
4
M
0
25000.0
0.0
D
2019-12-18
Common Stock
25000
20295
D
Non-Qualified Stock Option (right to buy)
30.63
2015-11-05
4
M
0
75000.0
0.0
D
2020-12-14
Common Stock
75000
46736
D
Represents volume-weighted average price of sales of 9,555 shares of Company stock on November 6, 2015 at prices ranging from $562.00 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 6, 2015 at each separate price.
Represents volume-weighted average price of sales of 8,345 shares of Company stock on November 6, 2015 at prices ranging from $563.00 to $563.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 6, 2015 at each separate price.
Represents volume-weighted average price of sales of 2,100 shares of Company stock on November 6, 2015 at prices ranging from $564.00 to $564.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 6, 2015 at each separate price.
Represents volume-weighted average price of sales of 9,694 shares of Company stock on November 9, 2015 at prices ranging from $558.00 to $558.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
Represents volume-weighted average price of sales of 1,500 shares of Company stock on November 9, 2015 at prices ranging from $559.00 to $559.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
Represents volume-weighted average price of sales of 3,900 shares of Company stock on November 9, 2015 at prices ranging from $560.00 to $560.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
Represents volume-weighted average price of sales of 500 shares of Company stock on November 9, 2015 at prices ranging from $561.07 to $561.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
Represents volume-weighted average price of sales of 5,607 shares of Company stock on November 9, 2015 at prices ranging from $562.00 to $562.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
Represents volume-weighted average price of sales of 900 shares of Company stock on November 9, 2015 at prices ranging from $563.00 to $563.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.
/s/**Neil Stahl
2015-11-09